In a report released today, David Deckelbaum from TD Cowen maintained a Hold rating on Albemarle (ALB – Research Report), with a price target of $130.00. The company’s shares closed yesterday at $133.20.
According to TipRanks, Deckelbaum is an analyst with an average return of -9.4% and a 35.04% success rate. Deckelbaum covers the Energy sector, focusing on stocks such as EQT, APA, and Coterra Energy.
In addition to TD Cowen, Albemarle also received a Hold from Mizuho Securities’s John Roberts CFA in a report issued on February 26. However, yesterday, BMO Capital maintained a Buy rating on Albemarle (NYSE: ALB).
See today’s best-performing stocks on TipRanks >>
ALB market cap is currently $15.64B and has a P/E ratio of 9.97.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Albemarle (ALB) Company Description:
Albemarle Corp. is a specialty company, which engages in developing, manufacturing, and marketing of chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, transportation, pharmaceuticals, crop production, food-safety, and custom chemistry services. It operates through the following segments: Lithium, Bromine Specialties, and Catalysts. The Lithium segment engages in developing and manufacture of basic lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and value-added lithium specialties and reagents. The Bromine Specialties segment consists of bromine and bromine-based business includes products used in fire safety solutions and other specialty chemicals applications. The Catalysts segment contain two product lines: clean fuels technologies, which is primarily composed of hydro processing catalysts, and heavy oil upgrading that comprises of fluidized catalytic cracking catalysts and additives. The company was founded in 1993 and is headquartered in Charlotte, NC.
Read More on ALB:
- Albemarle management to meet with Oppenheimer
- GoodRx upgraded, Fisker downgraded: Wall Street’s top analyst calls
- Albemarle initiated with a Peer Perform at Wolfe Research
- Early notable gainers among liquid option names on February 29th
- Early notable gainers among liquid option names on February 27th
